# A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

> clinical trial · VERIFIED · 2026-06-18

Status: RECRUITING · Sponsor: AbbVie · Condition: Primary Open Angle Glaucoma

- Company: AbbVie
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT06822738

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.